G
Genedrive PLC
LSE:GDR
Genedrive PLC
LSE:GDR
Price:
2.5 GBX
11.11%
Market Closed
Updated:
May 14, 2024
Genedrive PLC
Income from Continuing Operations
|
Genedrive PLC
Income from Continuing Operations Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
G
|
Genedrive PLC
LSE:GDR
|
Income from Continuing Operations
-£5m
|
CAGR 3-Years
31%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-13%
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Income from Continuing Operations
-£154.5m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Income from Continuing Operations
-£776k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Income from Continuing Operations
£724k
|
CAGR 3-Years
22%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Income from Continuing Operations
£15m
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Income from Continuing Operations
£16.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Genedrive PLC's Income from Continuing Operations?
Income from Continuing Operations
-5m
GBP
-5m
GBP
Based on the financial report for Dec 31, 2023, Genedrive PLC's Income from Continuing Operations amounts to -5m GBP.
What is Genedrive PLC's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-13%
-13%
Over the last year, the Income from Continuing Operations growth was -10%. The average annual Income from Continuing Operations growth rates for Genedrive PLC have been 31% over the past three years , 10% over the past five years , and -13% over the past ten years .
You don't have any saved screeners yet
